Hikma Pharmaceutical | HIK - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
Almirall EUR 1.53B 43.26M 2026-06
argenx SE USD 8.42B 1.09B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Autolus Therapeutics Ltd USD 108.83M 69.3M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Fresenius EUR 19.77B 1.14B 2025-12
Genmab DKK 5.85B 96M 2025-12
GlaxoSmithKline GBP 17.64B 223M 2026-06
GRIFOLS EUR 5.46B 171M 2026-03
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lakefront Biotherapeutics EUR 3.25B 17.5M 2026-03
Lonza CHF 9.13B 513M 2025-12
Merck EUR 29.74B 1.15B 2026-03
Orion EUR 1.27B 146.5M 2026-06
Recordati EUR 2.06B 140.52M 2026-03
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 72.81B 1.1B 2026-03
UCB EUR 10.87B 1.18B 2025-12